[
    {
        "pregunta": "1. What are the key guiding principles for determining the optimal timing of elective hip or knee arthroplasty for patients with symptomatic moderate-to-severe osteoarthritis or advanced symptomatic osteonecrosis with secondary arthritis?",
        "respuesta": "I don't have enough information to provide the key guiding principles for determining the optimal timing of elective hip or knee arthroplasty for patients with symptomatic moderate-to-severe osteoarthritis or advanced symptomatic osteonecrosis with secondary arthritis based on the retrieved documents.",
        "contexto": [
            "2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective  American College of Rheumatology      6E2D3A150A173E976859B79AA172C610 10.1002/acr.25175 Submitted for publication March 10, 2023; accepted in",
            "2023 American College of Rheumatology (ACR) and American Association of Hip and Knee Surgeons (AAHKS) Clinical Practice Guideline for the Optimal Timing of Elective Total Hip or Knee Arthroplasty for Patients with Symptomatic Moderate to Severe Osteoarthritis or Osteonecrosis Who Have Failed Nonoperative Therapy      CD97A058698E0312A0F52032DE0ABAAD 10.1002/art.42630  b. Delay TJA in order to achieve nicotine cessation or reduction. c. Delay TJA to improve glycemic control in patients with",
            "this guideline provides evidence-based recommendations regarding the optimal timing of elective TJA in patients who have symptomatic moderate-to-severe OA or advanced symptomatic ON with secondary arthritis for whom nonoperative treatment has been ineffective and who have chosen to undergo surgical treatment after a shared decision-making process with their physician. Further recommendations regarding the timing of TJA in patients who have specific medical comorbidities and risk factors are",
            "implants typically reserved for revision arthroplasty. Proceeding with operative treatment in these cases is recommended because delaying surgery increases the technical difficulty of the procedure and does not improve outcomes after the procedure DISCUSSION This guideline provides evidence-based recommendations regarding the optimal timing of elective TJA in patients who have symptomatic moderate-to-severe OA or advanced symptomatic ON with secondary arthritis who have chosen to undergo",
            "recommendations for the optimal timing of TJA in patients with symptomatic moderate-to-severe OA or advanced symptomatic ON with secondary arthritis for whom nonoperative therapy has been ineffective and who elected to undergo TJA, and to evaluate benefits of delays of surgery for additional nonoperative arthritis treatments or to achieve specific targets for medical optimization. This guideline is intended for use during a shared decision-making process with this defined group of patients and"
        ]
    },
    {
        "pregunta": "2. What nonoperative therapies should be tried and found ineffective before considering elective total joint arthroplasty (TJA) for patients with radiographically moderate-to-severe OA or advanced ON with secondary arthritis?",
        "respuesta": "The nonoperative therapies that should be tried and found ineffective before considering elective total joint arthroplasty (TJA) for patients with radiographically moderate-to-severe OA or advanced ON with secondary arthritis include physical therapy, nonsteroidal anti-inflammatory drugs (NSAIDs), braces, intraarticular injections (e.g., glucocorticoids or viscosupplementation), and weight reduction. It is important for patients to have completed and not improved with at least one trial of appropriate nonoperative therapy before considering TJA.",
        "contexto": [
            "NSAIDs, braces or ambulatory aids, as well as intraarticular injections. Importantly, our defined population consists of patients who have moderate-to-severe symptomatic and radiographic OA or advanced symptomatic ON with secondary arthritis who already unsuccessfully tried a course of nonoperative treatment prior to indication for TJA. The results from this systematic review found that the efficacy of additional nonoperative treatments in these patients indicated for TJA is limited. However,",
            "recommendations for the optimal timing of TJA in patients with symptomatic moderate-to-severe OA or advanced symptomatic ON with secondary arthritis for whom nonoperative therapy has been ineffective and who elected to undergo TJA, and to evaluate benefits of delays of surgery for additional nonoperative arthritis treatments or to achieve specific targets for medical optimization. This guideline is intended for use during a shared decision-making process with this defined group of patients and",
            "this guideline provides evidence-based recommendations regarding the optimal timing of elective TJA in patients who have symptomatic moderate-to-severe OA or advanced symptomatic ON with secondary arthritis for whom nonoperative treatment has been ineffective and who have chosen to undergo surgical treatment after a shared decision-making process with their physician. Further recommendations regarding the timing of TJA in patients who have specific medical comorbidities and risk factors are",
            "shared decision-making process with their physician and have completed and did not improve with ≥1 trials of appropriate nonoperative therapy such as physical therapy, NSAIDs, and/or intraarticular injections (e.g., glucocorticoids or viscosupplementation). This does not include patients who have mild radiographic OA, patients who have minimal pain and/or disability, or patients who have not tried nonoperative therapy. This guideline does not address arthroplasty for patients who have rheumatic",
            "10.1002/acr.25175 Submitted for publication March 10, 2023; accepted in revised form June 14, 2023.  INTRODUCTION Patients who have osteoarthritis (OA) and advanced symptomatic osteonecrosis (ON) with secondary arthritis can benefit from nonoperative treatment, e.g., physical therapy, nonsteroidal antiinflammatory drugs (NSAIDs), braces, intraarticular injections, and weight reduction For this guideline, our population consists of patients who have moderate-to-severe pain and loss of function"
        ]
    },
    {
        "pregunta": "3. How should patient preferences be incorporated into the decision-making process for elective TJA in patients with symptomatic OA or ON?",
        "respuesta": "Patient preferences should be incorporated into the decision-making process for elective total joint arthroplasty (TJA) in patients with symptomatic osteoarthritis (OA) or osteonecrosis (ON) through a shared decision-making process with their physician. This process involves discussing the patient's values, goals, and preferences regarding their treatment options. It is important to consider the patient's input and concerns when determining the optimal timing of TJA and to involve them in the decision-making process to ensure that the treatment aligns with their individual needs and preferences.",
        "contexto": [
            "this guideline provides evidence-based recommendations regarding the optimal timing of elective TJA in patients who have symptomatic moderate-to-severe OA or advanced symptomatic ON with secondary arthritis for whom nonoperative treatment has been ineffective and who have chosen to undergo surgical treatment after a shared decision-making process with their physician. Further recommendations regarding the timing of TJA in patients who have specific medical comorbidities and risk factors are",
            "recommendations for the optimal timing of TJA in patients with symptomatic moderate-to-severe OA or advanced symptomatic ON with secondary arthritis for whom nonoperative therapy has been ineffective and who elected to undergo TJA, and to evaluate benefits of delays of surgery for additional nonoperative arthritis treatments or to achieve specific targets for medical optimization. This guideline is intended for use during a shared decision-making process with this defined group of patients and",
            "implants typically reserved for revision arthroplasty. Proceeding with operative treatment in these cases is recommended because delaying surgery increases the technical difficulty of the procedure and does not improve outcomes after the procedure DISCUSSION This guideline provides evidence-based recommendations regarding the optimal timing of elective TJA in patients who have symptomatic moderate-to-severe OA or advanced symptomatic ON with secondary arthritis who have chosen to undergo",
            "criteria) As noted, TJA is the only approved definitive therapy for moderate-to-severe symptomatic OA of the hip or knee, yet racial disparities in arthroplasty utilization have persisted for decades The Patient Panel was instrumental in the development of this guideline and provided valuable insight into how best to apply these recommendations in the clinical setting. In particular, the Patient Panel stressed the importance of the shared decisionmaking process when indicating a patient for",
            "symptomatic ON with secondary arthritis who have chosen to undergo surgical treatment after a shared-decision making process with their physician after nonoperative therapy has lost efficacy. Further recommendations regarding the timing of TJA in patients with specific medical comorbidities and risk factors are also provided. The evidence for each PICO question was very low quality except for physical therapy and nicotine cessation, which had low quality of evidence, primarily due to"
        ]
    },
    {
        "pregunta": "4. What are the recommendations regarding modifying risk factors such as BMI, glycemic control, and nicotine dependence before proceeding with TJA?",
        "respuesta": "The guidelines recommend the following when considering total joint arthroplasty (TJA) for patients with various risk factors:\n\n1. In patients with a BMI of 35–39, it is conditionally recommended to proceed with TJA without delaying to achieve weight reduction to a BMI of <35.\n2. For patients with poorly controlled diabetes mellitus, it is conditionally recommended to delay TJA to improve glycemic control.\n3. In patients with nicotine dependence, it is conditionally recommended to delay TJA for nicotine use reduction/cessation.\n\nThese recommendations are based on the identified risk factors and their impact on surgical outcomes.",
        "contexto": [
            "criteria to mitigate their surgical risk. However, while these factors are clearly associated with increased risk for adverse events, it is unknown whether delaying surgery in order to achieve a specific glycemic end point, weight or body mass index (BMI) target, or absolute nicotine cessation leads to improved outcomes after TJA The purpose of this clinical practice guideline was to develop consensus on evidence-based recommendations for the optimal timing of TJA in patients with symptomatic",
            "| In our defined population with poorly controlled diabetes mellitus, we conditionally recommend delaying TJA to improve glycemic control. | Very low                 |\n| In our defined population with nicotine dependence, we conditionally recommend delaying arthroplasty for nicotine use reduction/cessation. | Low                       |",
            "to achieve weight reduction to a BMI of <35. Very low 9 77-130 In our defined population with poorly controlled diabetes mellitus, we conditionally recommend delaying TJA to improve glycemic control. Very low 10 131-156 In our defined population with nicotine dependence, we conditionally recommend delaying TJA for nicotine use reduction/cessation. Low 11 157-180 In our defined population with bone loss with deformity or severe ligamentous instability, we conditionally recommend proceeding to",
            "|In our defined population with a BMI of 35–39, we conditionally recommend proceeding to TJA without delaying to achieve weight reduction to a BMI of &lt;35.|Very low|9|77–130|\n|In our defined population with poorly controlled diabetes mellitus, we conditionally recommend delaying TJA to improve glycemic control.|Very low|10|131–156|\n|In our defined population with nicotine dependence, we conditionally recommend delaying TJA for nicotine use reduction/cessation.|Low|11|157–180|",
            "particularly periprosthetic joint infection In our defined population with poorly controlled diabetes mellitus, we conditionally recommend delaying TJA to improve glycemic control. It is well-established that patients who have poor glycemic control have an increased risk of poor outcomes after TJA In our defined population with nicotine dependence, we conditionally recommend delaying TJA for nicotine use reduction/cessation. Nicotine use is associated with both increased medical and surgical"
        ]
    },
    {
        "pregunta": "5. What is the rationale behind the conditional recommendation to proceed to TJA without delay over delaying arthroplasty for a trial of physical therapy in the defined population?",
        "respuesta": "The rationale behind the conditional recommendation to proceed to total joint arthroplasty (TJA) without delay over delaying arthroplasty for a trial of physical therapy in the defined population is based on the balance of potential benefits and risks for the patient. The guideline suggests that patients who may benefit from TJA for symptomatic osteoarthritis or osteonecrosis should not be delayed in receiving surgical treatment if nonoperative therapies, including physical therapy, have not provided significant improvement. This recommendation is made considering the impact of pain and functional limitations on the patient's quality of life and the potential for TJA to provide more effective and lasting relief compared to ongoing nonoperative treatments. The decision to proceed to TJA without delay is aimed at addressing the patient's symptoms and improving their overall function and well-being in a timely manner.",
        "contexto": [
            "nonoperative therapy Certainty of Evidence In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty three months. Very low In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for a trial of physical therapy. Low In our defined population, we conditionally recommend proceeding to TJA without delay over delaying surgical treatment for a trial of nonsteroidal antiinflammatory drugs",
            "recommend proceeding to TJA without delay over delaying arthroplasty for a trial of physical therapy. Low 2 8-37 In our defined population, we conditionally recommend proceeding to TJA without delay over delaying surgical treatment for a trial of NSAIDs. Very low 3 38-46 In our defined population, we conditionally recommend proceeding to TJA without delay over delaying surgical treatment for a trial of braces and/or ambulatory aids. Very low 4 47-53 In our defined population, we conditionally",
            "<p>|Recommendation|Certainty of evidence|Based on the evidence report|Page numbers of evidence tables in the Supplementary Appendix†|\n|---|---|---|---|\n|In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty 3 months.|Very low|1|1–7|\n|In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for a trial of physical therapy.|Low|2|8–37|",
            "| In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for a trial of physical therapy. | Low                       |\n| In our defined population, we conditionally recommend proceeding to TJA without delay over delaying surgical treatment for a trial of nonsteroidal anti-inflammatory drugs (NSAIDs). | Very low                 |",
            "work or family obligations) or ongoing medical comorbidities that can be optimized prior to surgery. In these cases, patients may consider proceeding with nonoperative treatment (excluding intraarticular injections in some cases; see below) to provide pain relief while awaiting surgery. In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for a trial of physical therapy. In patients who are indicated for TJA, mandated physical therapy"
        ]
    },
    {
        "pregunta": "6. Why is mandated physical therapy not recommended to delay or avoid surgery for patients indicated for TJA in the clinical guideline?",
        "respuesta": "Mandated physical therapy is not recommended to delay or avoid surgery for patients indicated for total joint arthroplasty (TJA) in the clinical guideline due to the potential impact of further delay on patients' pain, loss of function, and worsening of medical comorbidities. The guideline suggests that patients who have already attempted nonoperative treatments for an extended period and are indicated for TJA should not be further delayed in receiving surgical treatment. The decision to proceed to TJA without delay is aimed at addressing the patient's symptoms and improving their overall function and well-being in a timely manner based on the available evidence and expert consensus in the guidelines.",
        "contexto": [
            "therapy. In patients who are indicated for TJA, mandated physical therapy is not recommended to delay or avoid surgery. While physical therapy may provide benefit in knee and hip OA , and physical therapy may be of benefit in anticipation of In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty 3 months. Very low 1 1-7 In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for a",
            "work or family obligations) or ongoing medical comorbidities that can be optimized prior to surgery. In these cases, patients may consider proceeding with nonoperative treatment (excluding intraarticular injections in some cases; see below) to provide pain relief while awaiting surgery. In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for a trial of physical therapy. In patients who are indicated for TJA, mandated physical therapy",
            "the recommendation is indirect and very low quality. Prior to presenting to an orthopedic surgeon and being indicated for TJA, patients in the defined population have already attempted nonoperative treatment for an extended period. Further delay to TJA may lead to increased pain, loss of function, and worsening of medical comorbidities due to limited mobility. Patients may elect to delay surgery due to personal reasons (e.g., work or family obligations) or ongoing medical comorbidities that can",
            "of bias, imprecision, as well as indirectness. No recommendations were supported by high or moderate quality evidence. There are many existing appropriateness criteria, insurance coverage determination policies, and other guidelines that comment on the indications for elective TJA The Voting Panel recommended against delaying TJA in our defined population for additional nonoperative treatment including physical therapy, NSAIDs, braces or ambulatory aids, as well as intraarticular injections.",
            "for our questions would entail randomizing patients indicated for TJA to receive surgical treatment or delay for a trial of additional nonsurgical treatment such as physical therapy, intraarticular injections, or bracing, and then assessing long-term patient-important outcomes. Patients and surgeons may have concerns about participating in studies in which patients could be randomized to delayed surgery or not being offered resources for risk factor modification such as poor glycemic control."
        ]
    },
    {
        "pregunta": "7. In patients with a BMI of ≥50, what is the conditional recommendation regarding proceeding to TJA without delaying to achieve weight reduction to a BMI of <50?",
        "respuesta": "The conditional recommendation regarding proceeding to total joint arthroplasty without delaying to achieve weight reduction to a BMI of less than 50 for patients with a BMI of 50 or higher is based on very low-certainty evidence. The recommendation suggests proceeding with the surgery without waiting for weight reduction to a BMI <50, as the potential benefits of timely surgery on relieving symptoms and improving function outweigh the risks of delay in this population.",
        "contexto": [
            "may place an unnecessary burden on the patient, with limited benefit on pain and function In our defined population with a BMI of ≥50, we conditionally recommend proceeding to TJA without delaying to achieve weight reduction to a BMI of <50. In our defined population with a BMI of 40-49, we conditionally recommend proceeding to TJA without delaying to achieve weight reduction to a BMI of <40. In our defined population with a BMI of 35-39, we conditionally recommend proceeding to TJA without",
            "with a BMI of 35-39, we conditionally recommend proceeding to TJA without delaying to achieve weight reduction to a BMI of <35. Recommendations 7-9 are conditional because there may be exceptions to these recommendations, and the evidence supporting a preoperative weight reduction and a rigid BMI or weight threshold is indirect and very low quality. A majority of the studies supporting all 3 recommendations were based on comparing TJA outcomes in patients who underwent bariatric surgical",
            "|In our defined population with a BMI of ≥50, we conditionally recommend proceeding to TJA without delaying to achieve weight reduction to a BMI of &lt;50.|Very low|7|77–130|\n|In our defined population with a BMI of 40–49, we conditionally recommend proceeding to TJA without delaying to achieve weight reduction to a BMI of &lt;40.|Very low|8|77–130|",
            "with a BMI of ≥50, we conditionally recommend proceeding to TJA without delaying to achieve weight reduction to a BMI of <50. Very low 7 77-130 In our defined population with a BMI of 40-49, we conditionally recommend proceeding to TJA without delaying to achieve weight reduction to a BMI of <40. Very low 8 77-130 In our defined population with a BMI of 35-39, we conditionally recommend proceeding to TJA without delaying to achieve weight reduction to a BMI of <35. Very low 9 77-130 In our",
            "40 -49, we conditionally recommend proceeding to surgery without delay to achieve weight reduction to BMI < 40. Very low In our defined population with body mass index (BMI) 35 -39, we conditionally recommend proceeding to surgery without delay to achieve weight reduction to BMI < 35. Very low In our defined population with poorly controlled diabetes mellitus, we conditionally recommend delaying TJA to improve glycemic control. Very low In our defined population with nicotine dependence, we"
        ]
    },
    {
        "pregunta": "8. For patients with poorly controlled diabetes mellitus, what is the conditional recommendation regarding delaying TJA to improve glycemic control?",
        "respuesta": "The conditional recommendation regarding delaying total joint arthroplasty (TJA) to improve glycemic control for patients with poorly controlled diabetes mellitus is based on very low-certainty evidence. The guideline suggests that in this defined population, it may be beneficial to delay TJA in order to improve glycemic control before proceeding with surgery.",
        "contexto": [
            "| In our defined population with poorly controlled diabetes mellitus, we conditionally recommend delaying TJA to improve glycemic control. | Very low                 |\n| In our defined population with nicotine dependence, we conditionally recommend delaying arthroplasty for nicotine use reduction/cessation. | Low                       |",
            "particularly periprosthetic joint infection In our defined population with poorly controlled diabetes mellitus, we conditionally recommend delaying TJA to improve glycemic control. It is well-established that patients who have poor glycemic control have an increased risk of poor outcomes after TJA In our defined population with nicotine dependence, we conditionally recommend delaying TJA for nicotine use reduction/cessation. Nicotine use is associated with both increased medical and surgical",
            "or reduction. c. Delay TJA to improve glycemic control in patients with diabetes mellitus, but we do not recommend a specific measure or threshold based on our literature review. d. Obesity by itself is not a reason for delaying surgery. There should be no inflexible weight or BMI target requirement for surgery, but weight loss should be strongly encouraged. e. Do not delay surgery in patients with severe deformity, bone loss, or in patients with a neuropathic joint. Recommendation for patients",
            "|In our defined population with a BMI of 35–39, we conditionally recommend proceeding to TJA without delaying to achieve weight reduction to a BMI of &lt;35.|Very low|9|77–130|\n|In our defined population with poorly controlled diabetes mellitus, we conditionally recommend delaying TJA to improve glycemic control.|Very low|10|131–156|\n|In our defined population with nicotine dependence, we conditionally recommend delaying TJA for nicotine use reduction/cessation.|Low|11|157–180|",
            "to achieve weight reduction to a BMI of <35. Very low 9 77-130 In our defined population with poorly controlled diabetes mellitus, we conditionally recommend delaying TJA to improve glycemic control. Very low 10 131-156 In our defined population with nicotine dependence, we conditionally recommend delaying TJA for nicotine use reduction/cessation. Low 11 157-180 In our defined population with bone loss with deformity or severe ligamentous instability, we conditionally recommend proceeding to"
        ]
    },
    {
        "pregunta": "9. Why is proceeding to TJA without delay recommended over delaying TJA for patients with bone loss with deformity or severe ligamentous instability in the defined population?",
        "respuesta": "The recommendation to proceed to total joint arthroplasty (TJA) without delay over delaying TJA for patients with bone loss with deformity or severe ligamentous instability in the defined population is based on the potential risks associated with further delay in surgery. Delaying TJA in these patients may lead to increased instability, juxtaarticular bone loss, or deformity, which can increase the technical difficulty of the procedure and the risk of failure, ultimately necessitating revision surgery. While patients with severe bone loss, deformity, or instability are already at an increased risk of revision or reoperation, this risk is likely to further escalate over time if surgery is delayed. Therefore, timely TJA is recommended in these cases to address these issues and optimize surgical outcomes. The decision to proceed without delay is intended to minimize the risks associated with ongoing instability and progressive bone deformities in this specific patient population.",
        "contexto": [
            "|In our defined population with bone loss with deformity or severe ligamentous instability, we conditionally recommend proceeding to TJA without delay over delaying TJA for optimization of non–life-threatening conditions.|There were no studies that either directly or indirectly answered our PICO question.|12|181|",
            "| In our defined population with bone loss with deformity or severe ligamentous instability, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for optimization of non-life-threatening conditions. | There were no studies that either directly or indirectly answered our PICO question. |",
            "In these patients, delaying TJA may lead to increased instability and increased juxtaarticular bone loss or deformity, which may increase the technical difficulty of the procedure as well as increase the risk of failure and need for revision. Although patients who have severe bone loss, deformity, or instability have an increased risk of revision or reoperation, this risk will likely only increase over time, with further delay in surgery. Thus, timely TJA should be performed in these cases when",
            "severe ligamentous instability, we conditionally recommend proceeding to TJA without delay over delaying TJA for optimization of non-life-threatening conditions. There were no studies that either directly or indirectly answered our PICO question. 12 181 In our defined population with a neuropathic joint, we conditionally recommend proceeding to TJA without delay over delaying for optimization of non-lifethreatening conditions. There were no studies that either directly or indirectly answered",
            "nonoperative therapy Certainty of Evidence In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty three months. Very low In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for a trial of physical therapy. Low In our defined population, we conditionally recommend proceeding to TJA without delay over delaying surgical treatment for a trial of nonsteroidal antiinflammatory drugs"
        ]
    },
    {
        "pregunta": "10. What are the considerations for patients with a neuropathic joint in the conditional recommendation to proceed to TJA without delay over delaying for optimization of non-life-threatening conditions?",
        "respuesta": "I don't have enough information to provide specific considerations for patients with a neuropathic joint in the conditional recommendation to proceed to total joint arthroplasty (TJA) without delay over delaying for optimization of non-life-threatening conditions.",
        "contexto": [
            "|In our defined population with a neuropathic joint, we conditionally recommend proceeding to TJA without delay over delaying for optimization of non–life-threatening conditions.|There were no studies that either directly or indirectly answered our PICO question.|13|181|</p>",
            "| In our defined population with a neuropathic joint, we conditionally recommend proceeding to TJA without delay over delaying for optimization of non-life-threatening conditions. | There were no studies that either directly or indirectly answered our PICO question. |</p>",
            "delay in surgery. Thus, timely TJA should be performed in these cases when medically appropriate. This recommendation is conditional because of the very low quality of evidence. In our defined population with a neuropathic joint, we conditionally recommend proceeding to TJA without delay over delaying for optimization of non-life-threatening conditions. There was no evidence for this recommendation; thus the recommendation is based on clinician and patient opinion and experiences. Patients who",
            "severe ligamentous instability, we conditionally recommend proceeding to TJA without delay over delaying TJA for optimization of non-life-threatening conditions. There were no studies that either directly or indirectly answered our PICO question. 12 181 In our defined population with a neuropathic joint, we conditionally recommend proceeding to TJA without delay over delaying for optimization of non-lifethreatening conditions. There were no studies that either directly or indirectly answered",
            "either directly or indirectly answered our PICO question. In our defined population with a neuropathic joint, we conditionally recommend proceeding to TJA without delay over delaying for optimization of non-lifethreatening conditions. There were no studies that either directly or indirectly answered our PICO question."
        ]
    }
]